The Neuroprotective Disease-Modifying Potential of Psychotropics in Parkinson's Disease

The Neuroprotective Disease-Modifying Potential of Psychotropics in Parkinson's Disease

Neuroprotective treatments in Parkinson's disease (PD) have remained elusive. Psychotropics are commonly prescribed in PD without regard to their pathobiological effects. The authors investigated the effects of psychotropics on pathobiological proteins, proteasomal activity, mitochondrial funct...

Full description

Bibliographic Details
Main Authors:	Lauterbach, Edward C., Fontenelle, Leonardo F., Teixeira, Antonio L.
Format:	Online
Language:	English
Published:	Hindawi Publishing Corporation 2012
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255316/

Similar Items

Neuroprotective Effects of Psychotropic Drugs in Huntington’s Disease
by: Lauterbach, Edward C.
Published: (2013)

Neuropsychiatry of Parkinson's Disease
by: Teixeira, Antonio L., et al.
Published: (2012)

Mitochondrial therapy for Parkinson’s disease: Neuroprotective pharmaconutrition may be disease-modifying
by: Kones, Richard
Published: (2010)

Neuroprotective potential of Beta vulgaris L. in Parkinson's disease
by: Nade, Vandana S., et al.
Published: (2015)

Psychiatric disorders in primary focal dystonia and in Parkinson’s disease
by: Dias, Fernando MV, et al.
Published: (2011)

The Promise of Neuroprotective Agents in Parkinson’s Disease
by: Seidl, Stacey E., et al.
Published: (2011)

Recent Advances on the Neuroprotective Potential of Antioxidants in Experimental Models of Parkinson’s Disease
by: Koppula, Sushruta, et al.
Published: (2012)

Microglial Ion Channels as Potential Targets for Neuroprotection in Parkinson's Disease
by: Richardson, Jason R., et al.
Published: (2013)

Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease
by: Ojha, Shreesh, et al.
Published: (2015)

Bacterial melanin in rat models of Parkinson's disease: a potential neuroprotective strategy
by: Petrosyan, Tigran
Published: (2015)

Neuroprotective Transcription Factors in Animal Models of Parkinson Disease
by: Blaudin de Thé, François-Xavier, et al.
Published: (2016)

Neuroprotective Activities of Palmitoylethanolamide in an Animal Model of Parkinson's Disease
by: Esposito, Emanuela, et al.
Published: (2012)

Neuroprotection by Nrf2 in Parkinson’s disease model
Published: (2011)

Medical Management of Parkinson’s Disease: Focus on Neuroprotection
by: Boll, Marie-Catherine, et al.
Published: (2011)

Erratum: The promise of neuroprotective agents in Parkinson's disease
by: Seidl, Stacey E., et al.
Published: (2013)

Neuroprotective Function of DJ-1 in Parkinson's Disease
by: Ariga, Hiroyoshi, et al.
Published: (2013)

Neuroprotection by immunomodulatory agents in animal models of Parkinson’s disease
by: Bridget Martinez, et al.
Published: (2018-01-01)

Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson's and Alzheimer's Diseases as Disease Modifying Agents
by: Youdim, Moussa B. H.
Published: (2010)

Psychotropic medication use among patients with celiac disease
by: Haley M. Zylberberg, et al.
Published: (2018-03-01)

Questionable Advertising of Psychotropic Medications and Disease Mongering
by: Lacasse, Jeffrey R, et al.
Published: (2006)

Gene Therapy: A Promising Approach for Neuroprotection in Parkinson’s Disease?
by: Valdés, Pamela, et al.
Published: (2016)

Identification of Licopyranocoumarin and Glycyrurol from Herbal Medicines as Neuroprotective Compounds for Parkinson's Disease
by: Fujimaki, Takahiro, et al.
Published: (2014)

Synthesis and Neuroprotective Action of Xyloketal Derivatives in Parkinson’s Disease Models
by: Li, Shichang, et al.
Published: (2013)

Neuroprotective effect of Thuja orientalis in haloperidol induced animal model of Parkinsons Disease
by: Revathy Saravanan, et al.
Published: (2016-11-01)

Targeting the noradrenergic system for anti-inflammatory and neuroprotective effects: implications for Parkinson's disease
by: Eoin O′Neill, et al.
Published: (2018-01-01)

c-Abl Inhibitors Enable Insights into the Pathophysiology and Neuroprotection in Parkinson’s Disease
by: Lindholm, Dan, et al.
Published: (2016)

Acylated but not des‐acyl ghrelin is neuroprotective in an MPTP mouse model of Parkinson's disease
by: Bayliss, Jacqueline A., et al.
Published: (2016)

Meclizine-induced enhanced glycolysis is neuroprotective in Parkinson disease cell models
by: Hong, Chien Tai, et al.
Published: (2016)

Melatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms
by: Mack, Josiel Mileno, et al.
Published: (2016)

Enhanced Neuroprotective Effects of Coadministration of Tetrandrine with Glutathione in Preclinical Model of Parkinson's Disease
by: Li, Xiang-Yun, et al.
Published: (2015)

In Vitro and in Vivo Neuroprotective Effects of Walnut (Juglandis Semen) in Models of Parkinson’s Disease
by: Choi, Jin Gyu, et al.
Published: (2016)

Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection
by: More, Sandeep Vasant, et al.
Published: (2015)

New drug treatments show neuroprotective effects in Alzheimer's and Parkinson's diseases
by: Hölscher, Christian
Published: (2014)

Neuroprotective Effects of Cuscutae Semen in a Mouse Model of Parkinson's Disease
by: Ye, Minsook, et al.
Published: (2014)

Spinal Cord Stimulation Exerts Neuroprotective Effects against Experimental Parkinson’s Disease
by: Shinko, Aiko, et al.
Published: (2014)

Neuroprotective and Therapeutic Strategies against Parkinson’s Disease: Recent Perspectives
by: Sarkar, Sumit, et al.
Published: (2016)

Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke
by: Hayakawa, Kazuhide, et al.
Published: (2010)

Potential Molecular and Cellular Mechanism of Psychotropic Drugs
by: Seo, Myoung Suk, et al.
Published: (2014)

Tetrahydrohyperforin: a neuroprotective modified natural compound against Alzheimer's disease
by: Montecinos-Oliva, Carla, et al.
Published: (2015)

Astaxanthin as a Potential Neuroprotective Agent for Neurological Diseases
by: Wu, Haijian, et al.
Published: (2015)